Comparing Minibeam and Broad-Beam Radiation Therapy for Glioma Cells
Author Information
Author(s): Gil Silvia, Sarun Sukhéna, Biete Albert, Prezado Yolanda, Sabés Manel
Primary Institution: Centre d'Estudis en Biofísica, Faculty of Medicine, Autonomous University of Barcelona
Hypothesis
The study aims to compare the effectiveness of Minibeam Radiation Therapy (MBRT) and broad-beam synchrotron radiation in treating F98 glioma rat cells.
Conclusion
Minibeam radiation therapy showed a higher effectiveness in inducing early apoptosis in glioma cells compared to broad-beam radiation.
Supporting Evidence
- Minibeam radiation therapy led to a higher proportion of early apoptotic cells compared to broad-beam radiation.
- The endpoint for both radiation types was established around 12 Gy based on cell survival.
- Higher doses (≥ 24 Gy) resulted in a decrease in early apoptotic cells for minibeam therapy.
Takeaway
This study looked at two types of radiation therapy to see which one works better for treating brain cancer cells. The minibeam method was found to be more effective at making the cancer cells die early.
Methodology
F98 glioma cells were irradiated with either minibeam or broad-beam synchrotron radiation, and cell survival and apoptosis were assessed using flow cytometry and metabolic activity tests.
Limitations
The study is limited to in vitro experiments and may not fully represent in vivo responses.
Participant Demographics
F98 glioma rat cells were used in the study.
Statistical Information
P-Value
0.0002
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website